These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16428882)

  • 1. uPAR (CD87) as a biocompatibility marker of dialysis membrane.
    Sohka T; Ohno T; Ichinose M; Okonogi H; Kawaguchi Y; Hosoya T; Nakamura K; Kataoka E; Suzuki M; Koremoto M; Sumita M; Shirai T; Kasai K
    Blood Purif; 2006; 24(2):236-46. PubMed ID: 16428882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling: a 'fishing expedition' in search of dialysis biocompatibility.
    Pecoits-Filho R
    Blood Purif; 2006; 24(2):234-5. PubMed ID: 16428881
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer.
    Lee KH; Bae SH; Lee JL; Hyun MS; Kim SH; Song SK; Kim HS
    Oncology; 2004; 66(3):210-7. PubMed ID: 15218312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.
    Wilhelm OG; Wilhelm S; Escott GM; Lutz V; Magdolen V; Schmitt M; Rifkin DB; Wilson EL; Graeff H; Brunner G
    J Cell Physiol; 1999 Aug; 180(2):225-35. PubMed ID: 10395292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.
    Fazioli F; Resnati M; Sidenius N; Higashimoto Y; Appella E; Blasi F
    EMBO J; 1997 Dec; 16(24):7279-86. PubMed ID: 9405357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells.
    Jardí M; Inglés-Esteve J; Burgal M; Azqueta C; Velasco F; López-Pedrera C; Miles LA; Félez J
    Thromb Haemost; 1996 Dec; 76(6):1009-19. PubMed ID: 8972026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of cellulosic and synthetic membranes assessed by leukocyte activation.
    Hernández MR; Galán AM; Cases A; Lopez-Pedret J; Pereira A; Tonda R; Bozzo J; Escolar G; Ordinas A
    Am J Nephrol; 2004; 24(2):235-41. PubMed ID: 15031626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation cascade activation causes CC chemokine receptor-2 gene expression and mononuclear cell activation in hemodialysis patients.
    Pertosa G; Simone S; Soccio M; Marrone D; Gesualdo L; Schena FP; Grandaliano G
    J Am Soc Nephrol; 2005 Aug; 16(8):2477-86. PubMed ID: 15976001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
    Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
    Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
    Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
    Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group A streptococcal surface GAPDH, SDH, recognizes uPAR/CD87 as its receptor on the human pharyngeal cell and mediates bacterial adherence to host cells.
    Jin H; Song YP; Boel G; Kochar J; Pancholi V
    J Mol Biol; 2005 Jul; 350(1):27-41. PubMed ID: 15922359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.